Arnaoutakis Dean J, Deroo Elise P, McGlynn Patrick, Coll Maxwell D, Belkin Michael, Hentschel Dirk M, Ozaki C Keith
Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, Mass.
Division of Renal Medicine, Brigham and Women's Hospital, Boston, Mass.
J Vasc Surg. 2017 Nov;66(5):1497-1503. doi: 10.1016/j.jvs.2017.04.075. Epub 2017 Jul 29.
Brachial-cephalic arteriovenous fistulas (BCFs) are associated with high-flow volumes, leading to potential risks such as arm swelling, steal syndrome, pseudoaneurysm (due to a pressurized access), and cephalic arch stenosis. We hypothesized that a proximal radial-cephalic fistula (prRCF) configuration mitigates these risks because a lower flow state is created. Furthermore, we also hypothesized that despite these lower flows, patencies (primary, primary assisted, secondary) are sustained.
Leveraging a prospectively collected database supplemented with detailed medical record data, analyses of patients undergoing BCF and prRCF were completed (November 2008 through March 2016). Preoperative clinical and imaging characteristics, operative variables, and postoperative complications were reviewed. The primary end point was a composite of arm swelling, steal, and pseudoaneurysm at 2 years. Fistulograms and interventions (surgical revision, thrombectomy, endovascular treatment of cephalic arch stenosis) censored at 2 years were compared between configurations. Patencies were plotted using Kaplan-Meier techniques and compared using Cox proportional hazards.
During the study period, 345 arteriovenous fistulas and 72 prosthetic grafts were primarily placed; 56 patients underwent BCF and 50 patients underwent prRCF with a mean follow-up of 1.8 ± 1.7 (standard deviation) years. Except for prRCF patients being older, there was no difference between the groups with regard to preoperative characteristics. The artery diameter used for anastomosis was significantly larger in the BCF group (4.0 ± 1.1 mm vs 2.6 ± 0.8 mm; P < .001), with higher flow volumes at 6-week ultrasound examination (1060 ± 587 mL/min vs 735 ± 344 mL/min; P < .001). Complications (arm swelling, steal, pseudoaneurysm) were significantly more common in the BCF group (P = .02). There was a trend, albeit statistically insignificant, for the BCF group to require more cephalic arch stenosis interventions. Of those patients needing dialysis within 1 year, both BCF and prRCF were successfully used in the majority of patients (n = 27 [66%] vs n = 25 [63%]; P = 1.0). Unadjusted and adjusted primary, primary assisted, and secondary patency rates were similar between the groups.
prRCFs have fewer complications yet similar midterm durability compared with BCFs. When it is anatomically feasible, prRCFs should be constructed over BCFs because of their superior physiology and clinical outcomes.
头臂动静脉瘘(BCF)与高血流量相关,会导致诸如手臂肿胀、窃血综合征、假性动脉瘤(由于有压力的通路)和头臂弓狭窄等潜在风险。我们推测,近端桡动脉-头静脉瘘(prRCF)构型可减轻这些风险,因为其可形成较低的血流状态。此外,我们还推测,尽管血流量较低,但(初次、初次辅助、二次)通畅率仍可维持。
利用前瞻性收集的数据库并补充详细的病历数据,完成了对接受BCF和prRCF治疗的患者的分析(2008年11月至2016年3月)。回顾了术前临床和影像学特征、手术变量及术后并发症。主要终点是2年时手臂肿胀、窃血和假性动脉瘤的综合情况。比较了两种构型在2年时进行的瘘管造影和干预措施(手术修复、血栓切除术、头臂弓狭窄的血管内治疗)。使用Kaplan-Meier技术绘制通畅率曲线,并使用Cox比例风险模型进行比较。
在研究期间,共首次置入345例动静脉瘘和72例人工血管移植物;56例患者接受了BCF治疗,50例患者接受了prRCF治疗,平均随访时间为1.8±1.7(标准差)年。除prRCF组患者年龄较大外,两组术前特征无差异。BCF组用于吻合的动脉直径明显更大(4.0±1.1mm对2.6±0.8mm;P<.001),在6周超声检查时血流量更高(1060±587mL/min对735±344mL/min;P<.001)。并发症(手臂肿胀、窃血、假性动脉瘤)在BCF组明显更常见(P=.02)。BCF组需要更多头臂弓狭窄干预措施,尽管无统计学意义,但有此趋势。在1年内需要透析的患者中,大多数患者BCF和prRCF均成功使用(n = 27 [66%]对n = 25 [63%];P = 1.0)。两组间未调整和调整后的初次、初次辅助和二次通畅率相似。
与BCF相比,prRCF并发症更少,但中期耐久性相似。当解剖结构可行时,由于其优越的生理学特性和临床结果,应优先构建prRCF而非BCF。